Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Baggerly

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Clinical Chemistry|September 23, 2003
Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionizationKevin R Coombes, Herbert A Fritsche, Charlotte Clarke, et al.
Haematologica|June 30, 2017
High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemiaZhihong Zeng, Wenbin Liu, Twee Tsao, et al.
Cancer Informatics|May 10, 2011
Reproducibility of SELDI Spectra Across Time and LaboratoriesLixia Diao, Charlotte H Clarke, Kevin R Coombes, et al.
Cancer|October 15, 2010
Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancersKristy L Richards, Baili Zhang, Menghong Sun, et al.
Gynecologic Oncology|December 4, 2012
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancerCristina Ivan, Wei Hu, Justin Bottsford-Miller, et al.
Bioinformatics (Oxford, England)|June 12, 2021
Methylation-eQTL analysis in cancer researchYusha Liu, Keith A Baggerly, Elias Orouji, et al.
Blood|July 25, 2012
Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironmentZhihong Zeng, Yue Xi Shi, Twee Tsao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2013
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypesHiroko Masuda, Keith A Baggerly, Ying Wang, et al.
Oncotarget|December 17, 2014
Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380Xiao Huang, Mengru Cao, Li Wang, et al.
Molecular Cancer Research : MCR|August 5, 2021
Gene Body Methylation of the Lymphocyte-Specific Gene <i>CARD11</i> Results in Its Overexpression and Regulates Cancer mTOR SignalingMichael H McGuire, Santosh K Dasari, Hui Yao, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Clinical Chemistry|September 23, 2003
Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionizationKevin R Coombes, Herbert A Fritsche, Charlotte Clarke, et al.
Haematologica|June 30, 2017
High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemiaZhihong Zeng, Wenbin Liu, Twee Tsao, et al.
Cancer Informatics|May 10, 2011
Reproducibility of SELDI Spectra Across Time and LaboratoriesLixia Diao, Charlotte H Clarke, Kevin R Coombes, et al.
Cancer|October 15, 2010
Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancersKristy L Richards, Baili Zhang, Menghong Sun, et al.
Gynecologic Oncology|December 4, 2012
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancerCristina Ivan, Wei Hu, Justin Bottsford-Miller, et al.
Bioinformatics (Oxford, England)|June 12, 2021
Methylation-eQTL analysis in cancer researchYusha Liu, Keith A Baggerly, Elias Orouji, et al.
Blood|July 25, 2012
Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironmentZhihong Zeng, Yue Xi Shi, Twee Tsao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2013
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypesHiroko Masuda, Keith A Baggerly, Ying Wang, et al.
Oncotarget|December 17, 2014
Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380Xiao Huang, Mengru Cao, Li Wang, et al.
Molecular Cancer Research : MCR|August 5, 2021
Gene Body Methylation of the Lymphocyte-Specific Gene <i>CARD11</i> Results in Its Overexpression and Regulates Cancer mTOR SignalingMichael H McGuire, Santosh K Dasari, Hui Yao, et al.
Pageof 10